stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Cytomx Therapeutics IncCTMX
$2.120.47%-0.010

Cytomx Therapeutics Inc (CTMX)

Cytomx Therapeutics Inc Stock (CTMX) Financials Data

*All numbers in millions
Period End Date2026-09-302026-06-302026-03-312025-12-312025-09-30
Period Length3 Months3 Months3 Months3 Months3 Months
Revenues
19.04%1.69
1.4210.260.665.96
0.04%25.19
25.2029.9328.6021.73
Research and Development
6.35%16.48
17.6019.2421.2415.30
Operating Income/Loss
1.17%-23.50
-23.78-19.67-27.93-15.77
Income/Loss From Continuing Operations Before Tax
3.25%-19.94
-20.61-18.19-26.46-14.17
Income Tax Expense/Benefit
1.67%0.06
0.060.060.050.06
3.23%-20.00
-20.67-18.25-26.51-14.23
Attributable To Parent
3.23%-20.00
-20.67-18.25-26.51-14.23
Available To Common Stockholders, Basic
3.23%-20.00
-20.67-18.25--14.23
Basic Average Shares
0.08%219.11
218.94177.27-165.00
Diluted Average Shares
0.08%219.11
218.94177.27-165.00

Similar to CTMX